Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Latest updates in treatment for the field of HER2-positive breast cancer

Management of Metastatic Breast Cancer in HR+, HER2- Patients

Published: 8 Jul 2022

Views: 104

Rating:

Save

Dr Delia Guaqueta - Memorial Healthcare System, Hollywood, USA

Dr Delia Guaqueta speaks to ecancer at the ASCO Direct Highlights 2022 Miami Symposium about some of the latest updates in treatment for the field of HER2-positive breast cancer.

Firstly, she discusses the promising results of the HER2CLIMB study with the use of tucatinib benefiting patients - even showing activity in those with brain metastases.

Dr Guaqueta then details the DESTINY-Breast03 study, which evaluates the use of trastuzumab deruxtecan for metastatic HER2-positive breast cancer, with the treatment improving progression-free survival in patients.

Related Videos

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )

Multiple myeloma in a resource constrained setting

Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda

Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )

Updates on lung cancer from WCLC and ESMO 2023

Dr Luis Raez - Memorial Cancer Institute, Miami, USA

Updates on lung cancer from WCLC and ESMO 2023 ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )

CAR-T therapy and impact to cancer patient outcomes and experience of treatment

Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen...

CAR-T therapy and impact to cancer patient outcomes and experience of treatment ( Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen, Switzerland )

OncoAlert round up July 28th to August 3rd, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

Updates on HR-positive HER2-negative breast cancer

Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA

Updates on HR-positive HER2-negative breast cancer ( Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA )

Neo-adjuvant therapy for different cancers in the Philippines

Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines

Neo-adjuvant therapy for different cancers in the Philippines ( Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines )

IORT at Institute Paoli-Calmettes in France

Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France

IORT at Institute Paoli-Calmettes in France ( Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France )

More from ecancer